Dactinomycin
Back to searchMolecule Structure
Scientific Name
Dactinomycin
Description of the Drug
Dactinomycin is an actinomycin used to treat a wide variety of cancers.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00970
http://www.drugbank.ca/drugs/DB00970
Brand Name(s)
Cosmegen, Cosmegen lyovac, Dactinomycin
Company Owner(s)
Hisun Pharmaceutical Hangzhou Co Ltd, Recordati Rare Diseases Inc, American Regent Inc, Eugia Pharma Specialities Ltd, Meitheal Pharmaceuticals Inc, Xgen Pharmaceuticals Djb Inc, Hikma Pharmaceuticals Usa Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| DNA | NUCLEIC-ACID | INHIBITOR | CHEMBL2311221 |
Clinical Trial(s)
Unichem Links
| Atlas | Actinomycin D | |||||
| SureChEMBL | SCHEMBL3844 | |||||
| Human Metabolome Database | HMDB0015105 | |||||
| DrugBank | DB00970 | |||||
| PubChem: Thomson Pharma | 15015952 | |||||
| PubChem | 457193 | |||||
| NMRShiftDB | 70120284 | |||||
| LINCS | LSM-5783 | |||||
| Nikkaji | J3.209C | |||||
| BindingDB | 50089528 | 43866 | ||||
| EPA CompTox Dashboard | DTXSID9020031 | |||||
| DrugCentral | 774 | |||||
| Brenda | 127576 | 207528 | 229132 | 2941 | 207529 | 229131 |
| rxnorm | DACTINOMYCIN | COSMEGEN | ||||
| ChEBI | 27666 |
